WASHINGTON, April 18, 2016 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its "From Hope to Cures" campaign, highlighting the stories of rare blood and lung cancer survivors.
Today is possible. Tomorrow is possible. Each step brings us closer to a cure.
15 years after Jamie’s diagnosis with a rare blood cancer, she continues to fight. Today, there are more than 800 medicines in development to fight cancer. Thanks to the perseverance of America’s biopharmaceutical companies, the fight is closer to turning in Jamie’s favor.
There are more than 800 cancer medicines in development.
Each step brings us closer to a cure.
Rhys’ diagnosis isn’t his destiny.
The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines.
The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she's been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her.
Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled "We're Fighting Back," which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients.
The collection of ads will continue to be featured in print, radio, digital and social channels throughout the year. Advertisements and promotion will run on a variety of platforms in Washington, D.C., and select states.
"From Hope to Cures" launched in January 2014 to highlight the value biopharmaceutical innovation provides to patients, society and the economy. The campaign website features stories of real patients and researchers, data and information on fighting diseases and an interactive map showing the economic contributions of the industry.
About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
Share this article